JNJ — Johnson & Johnson Share News
0.000.00%
Last trade - 00:00- $610.38bn
- $638.66bn
- $94.19bn
J&J posts weak medical device sales, shares fall (updated)
Brief: J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business - WSJ
Johnson & Johnson Q3 sales rise on MedTech growth, lifts 2026 outlook
Johnson & Johnson slips after quarterly results
J&J beats earnings estimates; Middle East conflict weighs on medical device sales
PREVIEW: Johnson & Johnson earnings expected to decline in Q3
Brief: New Tremfya® Study Shows Consistent Perianal Fistula Remission Across Key Crohn's Disease Patient Subgroups
PREVIEW: Johnson & Johnson earnings expected to decline in Q3
What to Watch in the Day Ahead - Tuesday, October 13
Wall St Week Ahead-Bank earnings, CPI headline busy markets week as S&P 500 hovers near records
Wall St Week Ahead-Bank earnings, CPI headline busy markets week as S&P 500 hovers near records
Wall St Week Ahead-Bank earnings, CPI headline busy markets week as S&P 500 hovers near records
Boston Scientific sues J&J for patent infringement over heart procedure tool
Brief: SMAIO Signs Sales Agency Agreement With DePuy Synthes For US Market
Stryker taps insider Stiles to succeed industry veteran Lobo as CEO
Factbox: Global healthcare companies invest billions to boost US presence
Brief: Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data In Difficult-To-Treat Plaque Psoriasis With Proven Durability Through 2-Years, Affirming Its Use As A Powerful First Line Systemic Therapy
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit (updated)